These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18819144)

  • 1. Repetita iuvant.
    Colombo A
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):468-9. PubMed ID: 18819144
    [No Abstract]   [Full Text] [Related]  

  • 2. Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: results of a pooled analysis of two randomized studies.
    Alfonso F; Pérez-Vizcayno MJ; Hernandez R; Fernandez C; Escaned J; Bañuelos C; Bethencourt A; López-Mínguez JR; Angel J; Cequier A; Sabaté M; Morís C; Zueco J; Seabra-Gomes R;
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):459-67. PubMed ID: 18814274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.
    Belardi J
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):599. PubMed ID: 18360848
    [No Abstract]   [Full Text] [Related]  

  • 4. Gender medicine and drug eluting coronary stents.
    Kornowski R
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):814-6. PubMed ID: 21104730
    [No Abstract]   [Full Text] [Related]  

  • 5. Percutaneous UPLM revascularisation: the time has come.
    Goyal BK
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):1050. PubMed ID: 20517967
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-eluting stent in saphenous vein graft lesions.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
    [No Abstract]   [Full Text] [Related]  

  • 7. DES editorial. Is there a survival benefit?
    Thomas DM
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):644-5. PubMed ID: 18360857
    [No Abstract]   [Full Text] [Related]  

  • 8. Neovascular microchannels in sirolimus-eluting stent occlusion at late phase.
    Takano M; Yamamoto M; Seino Y; Mizuno K
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1202-3. PubMed ID: 21087758
    [No Abstract]   [Full Text] [Related]  

  • 9. Warning: this report does not address heavily calcified coronary arteries.
    Butman SM
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):643. PubMed ID: 20976745
    [No Abstract]   [Full Text] [Related]  

  • 10. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
    Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
    JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term complication after LM bifurcation treatment.
    Wainstein MV; Ribeiro JP
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):1045-9. PubMed ID: 20146313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stent strut fracture: seeing is believing.
    Carter AJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):619-20. PubMed ID: 18360854
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary stent fracture: the hidden truth of a problem more common than stent thrombosis.
    Carroll JD
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):88-9. PubMed ID: 19089948
    [No Abstract]   [Full Text] [Related]  

  • 15. Crush stenting with paclitaxel-eluting or sirolimus-eluting stents for the treatment of coronary bifurcation lesions.
    Chen S; Zhang J; Ye F; Zhu Z; Lin S; Tian N; Liu Z; Fang W; Chen Y; Sun X; Kwan TW
    Angiology; 2008; 59(4):475-83. PubMed ID: 18388098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete stent apposition: should we appose or oppose?
    Lindsey JB; Marso SP
    JACC Cardiovasc Interv; 2010 May; 3(5):495-7. PubMed ID: 20488405
    [No Abstract]   [Full Text] [Related]  

  • 17. Percutaneous coronary intervention for a right coronary artery stent occlusion using retrograde delivery of a sirolimus-eluting stent via a septal perforator.
    Utunomiya M; Katoh O; Nakamura S
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):475-80. PubMed ID: 19229979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple stent fractures at the site of coronary artery bypass insertion.
    Hetterich H; Rieber J
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):84-7. PubMed ID: 19089946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Too early to call.
    Waksman R
    Cardiovasc Revasc Med; 2012; 13(3):157-8. PubMed ID: 22652313
    [No Abstract]   [Full Text] [Related]  

  • 20. Late regression of Cypher in-stent restenosis.
    Yamaguchi H; Takaoka J; Miyamura A; Atsuchi N; Atsuchi Y; Kaneda H
    Cardiovasc Revasc Med; 2011; 12(5):341-2. PubMed ID: 21367672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.